We recently defined an element (ACTAATTGG) within the rat osteocalcin (OC) promoter at -84 to -92 which provides approximately 70% of basal promoter activity in osteoblastic cell lines and binds a specific nuclear factor found in OC-producing ROS 17/2.8 osteosarcoma cells. Since this element closely resembles the recently described Msx-1 (Hox 7.1) homeodomain DNA binding cognate, we examined rodent osteoblastic cells lines for expression of Msx homeodomain-encoding messages. We have found and cloned a cDNA for rat Msx-2 (Hox 8.1) from a ROS 17/2.8 library and detect high levels of expression in various osteoblastic cell lines (ROS 17/2.8, RCT3, RCTI) as well as in culture passage 3 neonatal rat calvarial osteoblastic cells. Little to no expression was detected in phenotypically immature MC3T3El osteoblastic cells or in a variety of nonosteoblastic (ROS 25/l, C2Cl2, TRAB 11) mesenchymal cell lines. Dexamethasone (DEX) downregulates Msx-2 message levels in both RCT3 and ROS 17/2.8 cells. Recombinant rat Msx-2 homeodomain expressed in Escherichia co/i as a glutathione-S-transferase fusion protein binds to the rat OC promoter region -74 to -100 as determined by gel shift analysis. Recognition is dependent upon the intact ACTAAlTGG motif at -84 to -92. In transient cotransfection assays using MC3T3El cells (which expresses very little or no endogenous Msx-2), Msx-2 suppresses the rat OC promoter 2-to 3-fold via the Msx-2 binding motif at -84 to -92. However, in ROS 17/2.8 cells, where a high level of endogenous Msx-2 mRNA is present, expression of exogenous Msx-2 does not suppress the rat OC promoter; surprisingly, Msx-2 further augments basal promoter activity by approximately 50-70%, again dependent upon the ACTAATTGG motif at -84 to -92. These data directly demonstrate that the Msx-2 homeodomain binds the rat OC promoter and that Msx-2 can act as a sequence-specific transcriptional regulator of the rat OC promoter in cultured osteoblastic cell lines. This activity is dependent upon the specific osteoblastic cellular context, similar to previous ob- 
INTRODUCTION
The mechanisms whereby the osteoblast phenotype is determined and expressed are poorly understood (1, 2). Unlike the story unfolding in studies of myogenesis, no equivalent of the MyoD family of master regulatory transcriptional switches has emerged (3). However, several observations point to the transforming growth factor-8 (TGFP) superfamily and certain homeobox (Hox) genes as providing combinatorial codes for initiating and maintaining osteogenesis within specific morphogenetic fields. Mutations in or abnormal expression of a large number of Hox genes have pronounced effects upon specific subsets of osseous structures (4, 5) suggesting that the different family members fulfill overlapping yet regionally distinct roles during osteogenesis. Depending upon the anatomical site and stage of development, the bone morphogenetic proteins (BMPs) or TGFB can initiate osteogenesis (6) . A link between BMPs and Hox gene expression in tooth formation was recently made; BMP4 from the dental epithelium induces expression of Msx-1 (Hox 7.1; Refs. 7 and 8) and Msx-2 (Hox 8.1; Refs. 7, 9-11) in dental mesenchyme during odontogenesis (11, 12) . Very recently, both Msx-1 (13) and were shown to affect development of specific ossified structures in the head. Thus, it is becoming apparent that homeodomaincontaining gene products are involved in the expression of the osteoblast phenotype. However, no bone-specific gene has previously been shown to be directly regulated by any homeodomain transcription factor.
Osteocalcin (OC) is a -6 kilodalton (kDa) -y-carboxylated protein whose expression in vertebrates is largely restricted to the mature osteoblasts of bone, the odontoblasts and cementoblasts of teeth, and hy- (19) (20) (21) (22) . The function of OC is as yet unknown. Current evidence suggests that OC potentiates osteoclast-mediated bone resorption, since OCdeficient bone less avidly recruits osteoclast-like mediators of bone resorption (23, 24) . In two osteopetrotic rat models, there are concomitant decreases in calvarial bone OC content and bone resorption (25). In vitro, OC can form a complex with osteopontin (26) an RGDcontaining sialoprotein that mediates integrin-dependent attachment of osteoclasts to bone (27, 28) . Genderand age-related changes in the pattern of OC deposition in human haversian bone have been documented, suggesting it may play a role in hormonal and age-related bone remodeling (29). Clinically, osteoblast-derived osteocalcin is readily detected in plasma by RIA, and levels correlate with states of high bone synthesis and bone turnover (30).
The cis elements responsible for osteoblast-specific expression of OC are only beginning to be elucidated. In mice, the proximal 3.9 kilobases (kb) of the human OC promoter give rise to transgene expression primarily in bone, with some calcitriol-inducible expression detected in brain as well (31). Similarly, the 1.8 kb of the rat OC gene immediately 5' to the transcriptional start site have been shown to direct temporally and spatially appropriate expression of a human GH gene reporter in bone in transgenic mice (32). We have cloned and functionally dissected this region of the rat OC promoter in vitro and have defined a minimal osteoblastic cell type-restricted promoter fragment (-121 to 32 relative to transcription initiation site; Ref. 33) . Within this fragment, we defined a motif ACTAATTGG at -84 to -92 that binds a factor found in the osteoblastic osteosarcoma ROS 17/2.8 cells, which produce large amounts of OC (34) and support rat OC promoter activity in transient transfection assays (22, 33) . This ACTAAlTGG element is responsible for approximately 70% of the basal OC promoter activity in ROS 17/2.8 osteoblastic cells (33). The ROS 17/2.8 nuclear factor recognizing this element was not detected in a fibroblastic sarcoma clone (ROS 25/l) which does not support rat OC promoter activity (33) or express endogenous OC (34) even though the two ROS clonal lines were derived from the same rat tumor (34). The identity of the ROS 17/2.8 nuclear factor is unknown. Intriguingly, this factor (33) also recognizes the DNA cognates of the POU (35, 36) We have now cloned a cDNA for rat Msx-2 from a ROS 17/2.8 library. We detect Msx-2 message in a variety of preosteoblastic and osteoblastic cell lines, as well as in RNA from passage 3 neonatal rat calvarial cells; no expression is detected in two fibroblastic lines or one myoblastic line examined. We show that the recombinant rat Msx-2 homeodomain indeed specifically binds to the rat OC promoter via the ACTAATTGG motif at -84 to -92. Furthermore, we show that Msx-2 acts as a sequence-dependent transcriptional suppressor of the rat OC proximal promoter. Transregulation of the rat OC promoter by Msx-2 is dependent upon the particular osteoblastic cellular background in which it is expressed, similar to observations made with homeodomain transcription factors in nonosseous systems (39-46). These data demonstrate for the first time direct regulation of an osteoblast-specific promoter by a Msx/Hox gene product and suggest that Msx-2 and other homeodomain transcription factors act as regional cell type-specific regulators of basal OC gene expression.
RESULTS
To look for Msx homeodomain encoding messages in osteoblastic cells, we generated by PCR from genomic DNA a probe containing the mouse Msx-2 exon 2 (10) and utilized this to screen an amplified X gt 11 cDNA library from ROS 17/2.8 cells. One million colonies were screened, and three positive clones that contained identical 1.8 kb cDNA inserts were obtained. Comparison of the sequences of these inserts to the reported sequences of the mouse, human, and quail Msx-2 cDNAs and the mouse genomic sequence (10) revealed that these cDNA clones encode an incompletely processed transcript: 0. 35 kb of intron 1, all of the coding region of exon 2 (0. 45 kb), and 1.1 kb of 3'-untranslated region (UTR) of the rat Msx-2 mRNA. The cDNA region encoding the rat Msx-2 homeodomain and carboxy terminus (submitted to GenBank; see Materials and Methods) is 94% identical to the reported mouse sequence; the predicted amino acid sequence of the coding region of the rat Msx-2 clone contains only a single conservative amino acid difference (Ser in rat vs. Gly in mouse) at residue 238 (10) in the region Cterminal to the homeodomain.
Using the coding region of exon 2 as a probe, we examined various osteoblastic and nonosteoblastic mesenchymal cell lines for expression of Msx-2 message. As shown in Fig. 1 A, high levels of expression could be detected in preosteoblastic (RCTl) and early osteoblastic (RCTS) cell lines derived from fetal rat calvariae (47). Basal levels were very high in RCT3 cells since the Msx-2 signal could be detected after an overnight exposure. Msx-2 mRNA was also readily detected in the the rat osteoblastic osteosarcoma ROS 17/2.8, which is phenotypically mature (1, 2, 15-l 7) in that it produces high basal levels of OC and forms ossified tumors in vivo (34). Two species of mRNA were detected, -2.4 and -1.4 kb size, similar to results described by others with RNA from mouse embryo (10). These two messages differed, at least in part, in their 3'-UTR, since a probe specific for this region only recognized the 2.4 kb message (Fig.  1B) . The smaller -0.8 kb signal seen with the 3'-UTR probe is as yet unidentified, but is always detected in cells expressing high levels of Msx-2 and parallels the intensity of the 2.4 kb message (not shown). However, little to no expression was seen in phenotypically immature (1, 2, 15-l 7) MC3T3El osteoblastic cells (48) in nonosteoblastic TRABl 1 or C2C12 cells (Fig 1 a) , or in ROS 25/l fibroblastic osteosarcomas (not shown). Expression of Msx-2 mRNA was down-regulated by DEX in RCT3 cells ( Fig. 2A ) and by DEX plus PTH in ROS 17/2.8 cells (Fig. 28) . In RCT3 cells, TGFPl attenuated DEX suppression, while TGFP2 modestly increased the already high basal levels approximately 2-fold ( Fig. 2A) . Fibroblast growth factor-2 (FGF-2) had little if any effect on Msx-2 message levels in RCT3 cells (Fig. 2a) (Fig. 3A) , which concomitantly express high levels of alkaline phosphatase but no demonstrable OC message (Fig. 38) . However, no significant modulation of Msx-2 message levels by DEX, TGFP, or FGF was noted in calvarial osteoblasts under these culture conditions (Fig. 3A) . In toto, these data along with previous observations provide strong evidence that Msx-2 is expressed in osteoblastic cells in vitro Ref. 38) and in vivo (14) suggesting that this homeodomaincontaining gene product may be a direct transcriptional regulator of osteoblast gene expression.
Since the basal promoter motif ACTAATTGG, which we defined in the rat OC promoter (33), closely resembles the Msx-1 DNA cognate (37), and since the encoded homeodomains of Msx-1 and Msx-2 are 98% identical, we wished to establish whether the Msx-2 homeodomain could bind this element in the rat OC promoter. To do this, we expressed the exon 2 coding region of rat Msx-2 (which includes the entire homeodomain) as a glutathione-S-transferase (GST Calvarial Osteoblasts A, Twenty micrograms of total RNA from passage 3 neonatal rat calvarial osteoblastic cells were analyzed by Northern blot using labeled 580.34 rat Msx-2 cDNA EcoRl fragment (see Materials and Methods) .
Note that the two Msx-2 messages are readily detected after 3 days exposure. Note also that DEX (0.1 PM), TGFPl (10 rig/ml), or FGF2 (10 rig/ml) treatment for 3 days did not significantly modulate Msx-2 message levels under these culture conditions (see Materials and Methods). B, The filter was stripped then reprobed simultaneously for alkaline phosphatase (AP), GAPDH, and osteocalcin (OC) messages. Lane R contains a 20 fig sample of ROS 17/2.8 total cellular RNA analyzed on the same blot. Note that while AP message is readily detected both in ROS 17/2.8 and rat calvarial osteoblastic cells, no OC message is detectable under these culture conditions in the rat calvarial protein in E. co/i (see Materials and Methods). After partial purification of this fusion protein with a glutathione affinity column, we examined the interaction of GST-Msx2 with the rat OC box oligo (region -74 to -100; see Ref. 33 ) by electrophoretic mobility gel shift assay. As shown in Fig. 4A , GST-Msx2 specifically bound to the rat OC box. The complex was specifically competed away by unlabeled OC box oligo (Fig. 4B,  lanes 3 and 4) , but not by a mutant OC box oligo (MUTHOX; lanes 6 and 7) in which the potential Msx binding site has been disrupted (see Fig. 4 legend; Ref. 33). The related oligo OCTA26, which is bound by the ROS 17/2.8 HOXBOX binding factor (33) and by Oct-3/4, Ott-6, and fngrailed (36), competed even more effectively for GST-Msx2 than the wild type rat OC box oligo, suggesting that it binds with higher affinity to the Msx-2 homeodomain (Fig. 48 , lanes 9 and 10). Other oligos, such as the CPl CAAT factor DNA cognate (49), and region -45 to -73 of the rat OC promoter (PPE5) did not compete, even at 1 go-fold molar excess (Fig. 4B, lanes 12, 13, 18 , and 19). The rat OC vitamin D response element (VDRE) oligo very weakly competed at a large molar excess for GST-Msx2 binding to the rat OC box. Thus, these data directly demonstrate that the rat OC promoter -74 to -100 is recognized by the homeodomain encoding region of Msx-2 (Hox 8.1). Since we have demonstrated that the intact AC-TAATTGG motif at -84 to -92 in the rat OC proximal promoter is required for binding of a bona fide homeodomain DNA binding protein, we now call this element the rat OC HOXBOX-1.
After establishing that Msx-2 was expressed in rodent osteoblastic cells and that the Msx-2 homeodomain bound to the rat OC HOXBOX-1, we wished to assess whether Msx-2 could transcriptionally regulate the rat OC promoter. We cotransfected various rat OCluciferase constructs with a full length mouse Msx-2/ Hox 8.1 (9) cDNA expression construct (Ref. 50; kind gift of Dr. D. Sassoon) into MC3T3El osteoblastic cells, since these cells support rat OC basal promoter activity (33) and do not possess detectable levels of endogenous Msx-2 mRNA (Fig. 1 A) . We found that both basal (Fig. 5A ) and forskolin-stimulated (Fig. 5C ) rat OC promoter activity in MC3T3El cells was inhibited by Msx-2 coexpression.
The effect was mediated via the ACTAAlTGG rat OC HOXBOX-1, since mutation of this motif to TACCATTGG (MUTHOX constructs), which precludes Msx-2 homeodomain binding (Fig. 4 ) almost completely eliminates the suppressive effect (Fig. 5) . The SV40 promoter (SV40 LUC) and rat BSP promoter (-795 BSPLUC) were not significantly modulated by Msx-2 cotransfection (Fig. 5) dependent upon coregulators that are cell-type specific (see Discussion). Therefore, we examined the ability of exogenous Msx-2 to transregulate the proximal rat OC promoter (-199 OCLUC) in ROS 17/2.8 cells, which express high levels of endogenous Msx-2 (Figs. 1 and 2) and OC (34). To our surprise, in ROS 17/2.8 cells Msx-2 could not suppress the proximal rat OC promoter; rather, against the background of already high endogenous Msx-2 mRNA expression, cotransfection of the Msx-2 expression construct further augmented rat OC promoter activity approximately 70% (Fig. 6 ). This effect was dependent upon the ACTAATTGG rat OC HOXBOX-1 motif and was apparently specific for Msx-2, since cotransfection with Msx-1 did not augment rat OC promoter activity in ROS 17/2.8 cells (Fig.  6 ). By contrast, the proximal 1 kb of the mouse Msx-2 promoter was not up-regulated by cotransfection with Msx-2 expression construct, even though it contains several imperfect HOXBOX like sequences in this region (10). It is mildly suppressed by cotransfection with the Msx-1 expression construct (Fig. 6) . Thus, it is apparent that Msx-2, like other homeodomain transcriptional regulators (36,39-46) is promoter-and cell typespecific in its transregulatory potential.
DISCUSSION
We show that Msx-2 is expressed in a variety of osteoblastic cell lines and in nonimmortalized neonatal rat calvarial osteoblasts, consistent with recent observations made with human trabecular osteoblastic cells in culture (38) . Importantly, we demonstrate, for the first time, recognition and transregulation of the osteoblast-specific rat OC promoter by Msx-2/Hex 8.1, a member of the homeobox gene family (7, 9, 10) . Genetic analysis has recently demonstrated that Msx-2 regulates cranial suture ossification in the developing skull (14). Our observation that Msx-2 mRNA is present in (Fig 1) . Note that Msx-2 suppresses both basal (Fig.  5, A detectable in ROS 17/2.8 and not in MC3T3El cells (Fig. 1) . By contrast, the ability of Msx-2 to suppress the rat OC proximal promoter via the rat OC HOXBOX-1 (ACTAATTGG) differs between these two osteoblastic cellular backgrounds (Figs. 5 and 6 Rat calvarial osteoblasts, RCTl , and RCT3 cell lines express high levels of Msx-2 mRNA but no detectable OC mRNA (Figs. 2A and 3; Ref. 47) . This is consistent with the observation that Msx-2 is a sequence-dependent suppressor of the rat OC promoter in cotransfection assays utilizing calvarial MC3T3El osteoblastic cells (Fig. 5) , which support OC transcription (33, 48) and express little if any endogenous Msx-2 mRNA (Fig. 1) . ROS 17/2.8 osteoblastic osteosarcoma cells, however, simultaneously express both OC (Ref. 34; Fig. 38 ) and Msx-2 (Figs. 1 and 2B) , and Msx-2 is not capable of suppressing the rat OC promoter in this cellular context (Fig. 6) . The reasons for this are unknown but may relate to the cell type-specific protein-protein interactions discussed above. Detailing the nature of these interactions and the temporo-spatial transcriptional activity of a rat OC promoter HOXBOX-1 mutant in transgenie mice will be necessary to define the precise role and regulation of this element during normal osteoblast differentiation. Although this HOXBOX-1 region is conserved between the reported mouse (52) and rat (22) OC promoters, the human OC promoter contains a noncanonical sequence at this position (53, 54). Differences between the character of the rat and human OC promoters in regulation by retinoids (19, 20) and cofactor requirement for recognition by vitamin D receptors (20, 55) have been noted, suggesting that these promoters are structurally divergent. Moreover, the recent discovery of multiple OC-related genes in rodents (18, 52) portends a larger OC gene family in humans, in which members may have promoter features more or less divergent from the rodent members. Functional dissection of the human, rodent, and avian genes should delineate any species-specific differences. Msx-1 and Msx-2 differ in their ability to augment the rat OC proximal promoter in ROS 17/2.8 cells (Fig. 6 ). Sassoon and co-workers (50) have demonstrated that Msx-1 but not Msx-2 transforms myoblasts and inhibits terminal differentiation.
Systematic mutation of Msx-2 and the construction of Msx family member chimeras should allow dissection of the structural features conferring functional differences between Msx-1 and Msx-2 in regulating growth and differentiation.
In these studies, we did not observe the significant calcitriol induction of Msx-2 mRNA that is seen in human trabecular bone cell cultures (38); we note only modest changes in Msx-2 message levels in response to DEX and TGFP in immortalized cell lines (Fig. 2 ) and no modulation in neonatal rat calvarial osteoblast cultures (Fig. 3) . However, the osteoblastic cells utilized in these experiments express at baseline high levels of Msx-2 mRNA (Figs. 2 and 3) . We have recently observed in other mouse calvarial osteoblastic cell lines variable degrees of Msx-2 induction by calcitriol, apparently related to cell density and/or proliferative state (D. Towler, unpublished observations). Since sequential elaboration of the osteoblast phenotype is highly influenced by proliferative status (2), hormonal effects on Msx-2 mRNA levels in these cells may be indirect, being cell stage or cell cycle dependent, as previously noted for a number of TGFP responses in osteoblasts (6).
MATERIALS AND METHODS

Cell Culture and Osteotropic Hormones
All media were obtained from GIBCO BRL (Gaithersburg, MD). Fetal calf serum was obtained from JRH Biosciences (Lenexa, KS). The fibroblastic (ROS 25/l) and osteoblastic (ROS 17/ 2.8) sarcoma cell lines arising from the same rat tumor were cultured as previously described (33). SV40 large T antigen immortalized osteoblastic cell lines obtained from fraction 1 (RCTl) and fraction 3 (RCTS) proteolytically released fetal rat calvariae cells were cultured as previously described (47 
